Form 4 for OPRX OptimizeRx Corp
Accepted 2021-10-19 00:00:00 ET · period of report 2021-10-18 · accession 0001213900-21-053526 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-19 | 2021-10-18 | OPRX | Silvestro Stephen L | Chief COMMERCIAL Off | M - OptEx | $7.51 | +13.2K | 13.2K | New | +$99.4K |
| D | 2021-10-19 | 2021-10-18 | OPRX | Silvestro Stephen L | Chief COMMERCIAL Off | S - Sale+OE | $85.38 | -13.2K | 0 | -100% | -$1.13M |
| D | 2021-10-19 | 2021-10-18 | OPRX | Silvestro Stephen L | Chief COMMERCIAL Off | M - OptEx | $0.00 | -13.2K | 65.0K | -17% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-10-18 | M | A | 13,241 | $7.51 | 13,241 | D | — | — | |
| 2 | Common | Common Stock pursuant to 10B5-1 plan | 2021-10-18 | S | D | 13,241 | $85.38 | 0 | D | — | — | (F1) These shares sold pursuant to a plan of disposition adopted on March 11, 2021 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. |
| 3 | Derivative | Stock Option | 2021-10-18 | M | D | 13,241 | $0.00 | 64,993 | D | $7.51 · 2020-09-30 to 2025-03-11 | 13,241 Common Stock |